Media Coverage
Could gym booster creatine also be a weapon against cancer?
Icon
Yahoo! News
Pembrolizumab monotherapy shows promise in desmoplastic melanoma
Icon
Oncology Times
Cytokine-armoured CAR T cells target glioblastoma while reducing treatment toxicity
Icon
Drug Target Review
Rare melanoma trial serves as model for advancing cancer immunotherapy
Icon
Targeted Oncology
Cancer in 2026: How immunotherapy is reshaping the odds
Icon
Cancer Research Institute
Rethinking immunotherapy for pancreatic cancer: A universal approach
Icon
Cancerworld
Neoadjuvant immunotherapy ‘a true shift’ in treatment for aggressive form of skin cancer
Icon
Healio
